Melgar, Cresencia S.

HRN: 18-31-23  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/08/2022
CIPROFLOXACIN 500MG (TAB)
11/08/2022
11/15/2022
PO
500mg
BID
Acute Pyelonephritis; T/C Adverse Drug Reaction To Ceftri
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: